Inhibition of neointima formation in an organ culture of human saphenous vein: A comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition

Journal of Vascular Surgery

Volumn 34, Issue 3, 2001, Pages 548-554

  Porter, Karen E ^a   Dickinson, Timothy ^b   London, Nicholas J M ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN-CONVERTING ENZYME 1; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE;

ARTICLE; COMPARATIVE STUDY; DRUG ANTAGONISM; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTIMA; ORGAN CULTURE TECHNIQUE; SAPHENOUS VEIN;

ASPARTIC ENDOPEPTIDASES; HUMANS; METALLOENDOPEPTIDASES; NEPRILYSIN; ORGAN CULTURE TECHNIQUES; SAPHENOUS VEIN; TUNICA INTIMA;

EID: 0035458364     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.115960     Document Type: Article

References (27)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Masood I, Porter KE, London NJM. Endothelin-1 is a mediator of intimal hyperplasia in an organ culture of human saphenous vein. Br J Surg 1997;84:499-503.
3. Masood I, Porter KE, London NJM, Pringle JH. Endothelin-1 expression in vein graft stenosis. J Vasc Surg 1996;24:901-2.
4. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
5. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al. Cloning of a cDNA encoding a non isopeptide selective subtype of the endothelin receptor. Nature 1990;348:732-5.
6. Tamirisa P, Frishman WH, Kumar A. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am Heart J 1995;130:601-10.
7. Doherty AM. Design and discovery of nonpeptide endothelin antagonists. Drug Discovery Today 1996;1:60-70.
8. Porter KE, Olojugba DH, Masood I, Pemberton M, Bell PRF, London NJM. Endothelin-B receptors mediate intimai hyperplasia in an organ culture of human saphenous vein. J Vasc Surg 1998;28:695-701.
9. Turner AJ, Murphy LJ. Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 1996;51:91-102.
10. Chackalamannil S, Chung S, Stamford AW, McKittrick BA, Wang Y, Tsai H, et al. Highly potent and selective inhibitors of endothelin converting enzyme. Bioorg Med Chem Lett 1996;6:1257-60.
11. Schmidt M, Kroger B, Jacob E, Seulberger H, Subkowski T, Otter R, et al. Molecular characterisation of human and bovine endothelin converting enzyme (ECE-1), FEBS Lett 1994;356:238-43.
12. Abassi Z, Golomb E, Keiser HR. Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin. Metabolism 1992;41:683-5.
13. Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 1990;265:14150-5.
14. Turner AJ, Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL and PEX. FASEB J 1997;11:355-64.
15. De Lombaert S, Ghai RD, Jeng AY, Trapani AJ, Webb RL. Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin converting enzyme. Biochem Biophys Res Comm 1994;204:407-12.
16. Yang Q, Battistini B, D'Orleans-Juste P, Jeng AY, Sirois P. Modulation of endothelin production and metabolism in guinea pig tracheal epithelial cells by peptidase inhibitors. Am J Respir Crit Care Med 1997;155:1884-9.
17. Soyombo AA, Angelini GD, Bryan AJ, Jasani B, Newby AC. Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol 1990;137:1401-10.
18. Porter KE, Varty K, Jones L, London NJM, Bell PRF. Human saphenous vein organ culture: a useful model of intimal hyperplasia? Eur J Vasc Endovasc Surg 1996;11:48-58.
19. Allen KE, Varty K, Jones L, Sayers RD, Bell PRF, London NJM. Human venous endothelium can promote intimal hyperplasia in a paracrine manner. J Vasc Surg 1994;19:577-84.
20. Varty K, Jones L, Porter KE, Bell PRF, London NJM. A quantitative study of long saphenous vein morphology in patients undergoing arterial surgery. Phlebology 1995;10:90-3.
21. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-8.
22. Battistini B, Brown M, Vane JR. Selective proteolytic activation and degradation of ETs and big ETs in parenchymal strips of the guinea pig lung. Biochem Biophys Res Comm 1995;207:675-81.
23. Varty K, Allen KE, Jones L, Sayers RD, Bell PRF, London NJM. Influence of Losartin, an angiotensin receptor antagonist, on neointimal proliferation in cultured human saphenous vein. Br J Surg 1994;81:819-22.
24. Minamino T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, et al. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 1997;95:221-30.
25. Takahashi M, Fukuda K, Shimada K, Barnes K, Turner AJ, Ikeda M, et al. Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells. Biochem J 1995;311: 657-65.
26. Tanabe S, Ueda M, Han Y-S, Kojima A, Nakatani T, Kishimoto T, et al. Up-regulation of endothelin-converting enzyme during the development of transplant renal arteriosclerosis in human renal allografts. Transplant Proc 1997;29:1517-9.
27. Wallace EM, Moliterni JA, Moskal MA, Neubert AD, Marcopulos N, Stamford LB, et al. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme. J Med Chem 1998;41:1513-23.